Article
An Alternatively Spliced p62 Isoform Confers Resistance to Chemotherapy in Breast Cancer
29 Aug 2022
Abstract excerpt
Resistance to chemotherapy remains a major obstacle to the successful treatment of breast cancer. More than 80% of patients who receive neoadjuvant chemotherapy (NAC) do not achieve a pathologic complete response. In this study, we report a novel p62 mRNA isoform with a short 3'-UTR (untranslated region; p62-SU, 662-nt) that is associated with chemoresistance in breast cancer cells and tissue specimens. The p62...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
